IL6 and myocardial infarction: In the ASSessing the effect of Anti-IL-6 treatment in Myocardial Infarction (ASSAIL-MI) trial, we showed that tocilizumab increased the myocardial salvage index (MSI) evaluated by cardiac MR imaging (CMR) in patients with ST-segment elevation MI (STEMI).